These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8568824)

  • 1. Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1,12-diaziridinyl-4,9-diazadodecane.
    Li Y; Eiseman JL; Sentz DL; Rogers FA; Pan SS; Hu LT; Egorin MJ; Callery PS
    J Med Chem; 1996 Jan; 39(1):339-41. PubMed ID: 8568824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
    Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
    Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of the pharmacodynamic properties of 2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinone.
    Ward TH; Danson S; McGown AT; Ranson M; Coe NA; Jayson GC; Cummings J; Hargreaves RH; Butler J
    Clin Cancer Res; 2005 Apr; 11(7):2695-701. PubMed ID: 15814651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles.
    Parker LL; Anderson FM; O'Hare CC; Lacy SM; Bingham JP; Robins DJ; Hartley JA
    Bioorg Med Chem; 2005 Apr; 13(7):2389-95. PubMed ID: 15755641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thiourea on survival and DNA cross-link formation in cells treated with platinum(II) complexes, L-phenylalanine mustard, and bis(2-chloroethyl)methylamine.
    Zwelling LA; Filipski J; Kohn KW
    Cancer Res; 1979 Dec; 39(12):4989-95. PubMed ID: 498125
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction.
    Hartley JA; Berardini M; Ponti M; Gibson NW; Thompson AS; Thurston DE; Hoey BM; Butler J
    Biochemistry; 1991 Dec; 30(50):11719-24. PubMed ID: 1751490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links.
    Ross WE; Ewig RA; Kohn KW
    Cancer Res; 1978 Jun; 38(6):1502-6. PubMed ID: 565677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.
    Danson S; Ranson M; Denneny O; Cummings J; Ward TH
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):851-61. PubMed ID: 17333193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5'-GNC preference for mustard cross-linking is preserved in a restriction fragment.
    Millard JT; Luedtke NW; Spencer RJ
    Anticancer Drug Des; 1996 Sep; 11(6):485-92. PubMed ID: 8836112
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and evaluation of the antitumor activity of 4,5-diamino-substituted 1,2-benzoquinones.
    Huang ZD; Chen YN; Menon K; Teicher BA
    J Med Chem; 1993 Jun; 36(13):1797-801. PubMed ID: 8515418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers.
    Gregson SJ; Howard PW; Gullick DR; Hamaguchi A; Corcoran KE; Brooks NA; Hartley JA; Jenkins TC; Patel S; Guille MJ; Thurston DE
    J Med Chem; 2004 Feb; 47(5):1161-74. PubMed ID: 14971896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytotoxic action of 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones and 1,3,5-triazine-4,6-(1 H,5 H)-diones in murine and human tumor cells.
    Hall IH; Taylor K; Izydore RA; Coleman DE; Mitchell JA; Cummings R
    Pharmazie; 1998 Jun; 53(6):398-405. PubMed ID: 9675770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking and sequence-specific alkylation of DNA by aziridinylquinones. 3. Effects of alkyl substituents.
    Hargreaves RH; O'Hare CC; Hartley JA; Ross D; Butler J
    J Med Chem; 1999 Jun; 42(12):2245-50. PubMed ID: 10377230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
    Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
    Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking and sequence specific alkylation of DNA by aziridinyl quinones. 2. Structure requirements for sequence selectivity.
    Hargreaves RH; Mayalarp SP; Butler J; McAdam SR; O'Hare CC; Hartley JA
    J Med Chem; 1997 Jan; 40(3):357-61. PubMed ID: 9022802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents.
    Anderson FM; O'Hare CC; Hartley JA; Robins DJ
    Anticancer Drug Des; 2000 Apr; 15(2):119-26. PubMed ID: 10901299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of a DNA-crosslinking azinomycin analogue.
    Casely-Hayford MA; Pors K; James CH; Patterson LH; Hartley JA; Searcey M
    Org Biomol Chem; 2005 Oct; 3(19):3585-9. PubMed ID: 16172698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
    Zwelling LA; Michaels S; Schwartz H; Dobson PP; Kohn KW
    Cancer Res; 1981 Feb; 41(2):640-9. PubMed ID: 7192601
    [No Abstract]   [Full Text] [Related]  

  • 20. Porphyrin-DNA cross-linking agent hybrids: chemical synthesis and biological studies.
    He H; Tian T; Wang P; Wu L; Xu J; Zhou X; Zhang X; Cao X; Wu X
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3013-6. PubMed ID: 15149636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.